Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Advanced Artificial Arm Moves Closer To Reach In Military Research Program

This article was originally published in The Gray Sheet

Executive Summary

Deka Research and Development Corp.--inventor of the iBOT stair-climbing wheelchair--is working with the Veterans Administration to enlist amputees for feasibility trials of a next-generation "strap-and-go" arm prosthesis

You may also be interested in...



FDA Approves Advanced Prosthetic Arm

FDA approved an advanced prosthetic arm from Deka R&D Corp. May 9 that has the ability to translate electrical signals from muscle into complex tasks.

Device Inventor Kamen Warns U.S. Industry Against Losing Innovation Edge

Dean Kamen, founder of DEKA Research and Development Corp., as well as inventor of the iBOT stair-climbing wheelchair, the Segway human transporter and numerous products in and outside the medtech field, told a roomful of medical device executives and regulators earlier this month that they risk losing the global lead in medical innovation if they cannot find a way to make the FDA approval process more predictable.

Device Inventor Kamen Warns U.S. Industry Against Losing Innovation Edge

Dean Kamen, founder of DEKA Research and Development Corp., as well as inventor of the iBOT stair-climbing wheelchair, the Segway human transporter and numerous products in and outside the medtech field, told a roomful of medical device executives and regulators earlier this month that they risk losing the global lead in medical innovation if they cannot find a way to make the FDA approval process more predictable.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT027696

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel